MedPath

Prevention of Coronary Heart Disease in Morbidly Obese Patients

Active, not recruiting
Conditions
Hypertension
Morbid Obesity
Type 2 DM
Obstructive Sleep Apnea
Osteoarthrosis
Interventions
Procedure: Bariatric Surgery
Registration Number
NCT00626964
Lead Sponsor
The Hospital of Vestfold
Brief Summary

The changes in risks of developing coronary heart disease in patients with morbid obesity after different weight loss interventions have not been extensively studied. The primary objective of this study is to investigate whether an intensive lifestyle intervention program in a tertiary care clinic (Spesialsykehuset for Rehabilitering) is comparable with a 7-week low-energy-diet followed by bariatric surgery in decreasing the risk of cardiovascular disease in these patients.

Detailed Description

Patients matching the eligibility criteria were divided into two groups (not randomized). One group underwent a 7 weeks Low-Energy-Diet before bariatric surgery, the other group participated in an intensive lifestyle intervention program for 3 months.

Data on arterial stiffness, body weight, body composition, blood pressure, blood samples, vital parameters are registered in the both groups at baseline, 7 weeks and after 1 year.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Morbidly Obese patients with BMI > 40, or BMI > 35 with comorbidity such as Hypertension, Obstructive Sleep Apnea, Weight Related Osteoarthrosis, Type 2 DM.
Exclusion Criteria
  • Participation in other weight loss program the last 12 months. Serious psychiatric conditions

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Lifestyle or bariatric surgeryBariatric SurgeryMorbid Obesity with BMI \>= 40 kg/m2 or BMI \>= 35 with Comorbidity
Primary Outcome Measures
NameTimeMethod
Arterial stiffness7 weeks and 1 year

Pulse wave velocity and augmentation index

Cardiovascular risk factors7 weeks and 1 year

Several biomarkers will be examined

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Morbid Obesity Center, Vestfold Hospital Trust

🇳🇴

Tønsberg, Norway

© Copyright 2025. All Rights Reserved by MedPath